The New York Times Co. and the Chicago Tribune sued Perplexity AI Inc., saying the artificial intelligence search startup is copying and distributing their exclusive content, the latest in a wave of lawsuits against AI developers.
The New York Times Co. and the Chicago Tribune sued Perplexity AI Inc., saying the artificial intelligence search startup is copying and distributing their exclusive content, the latest in a wave of lawsuits against AI developers.
A Houston-based private equity firm was stopped in its tracks when an investor cried foul as it tried to sell one of its assets to itself, one of the first times such a dispute has spilled into public view.
A Houston-based private equity firm was stopped in its tracks when an investor cried foul as it tried to sell one of its assets to itself, one of the first times such a dispute has spilled into public view.
A former commodities trader in Houston was ordered to spend three years behind bars after admitting to hiding hundreds of millions of dollars in losses from his employer to secure a hefty bonus.
A former commodities trader in Houston was ordered to spend three years behind bars after admitting to hiding hundreds of millions of dollars in losses from his employer to secure a hefty bonus.
David Smothermon, former chief executive officer of Trammo Gas, right, arrives at federal court in New York, US, on Tuesday, Nov. 25, 2025. Smothermon is scheduled to be sentenced on Tuesday after admitting to hiding hundreds of millions of dollars in losses from his employer to secure a hefty bonus.
Altice USA Inc. filed an antitrust lawsuit against some of its largest creditors Tuesday, an opening salvo ahead of potential discussions to restructure its $26 billion debt pile.
Altice USA Inc. filed an antitrust lawsuit against some of its largest creditors Tuesday, an opening salvo ahead of potential discussions to restructure its $26 billion debt pile.
BRAZIL - 2020/10/18: In this photo illustration the Altice USA logo seen displayed on a smartphone. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)
Minority shareholders in Oncoclínicas do Brasil Servicos Medicos SA want to question Goldman Sachs Group Inc. about whether the bank’s ownership stake in the Brazilian cancer treatment chain was misstated in the prospectus for its 2021 initial public offering.
Minority shareholders in Oncoclínicas do Brasil Servicos Medicos SA want to question Goldman Sachs Group Inc. about whether the bank’s ownership stake in the Brazilian cancer treatment chain was misstated in the prospectus for its 2021 initial public offering.